PKM and neoplasm: PKM2 functions as a transcriptional co-activator of HIF-1α and in ischemic CMs, this interaction has been shown to support metabolic reprogramming, reduce apoptosis, and enhance cell survival, indicating its CM-specific relevance beyond tumor biology.